Wednesday, December 22, 2021

Israeli study: Booster increases COVID-19 antibodies by 40 times

Assuta Hospital in Ashdod has published a new groundbreaking research showing that the booster dose of the COVID-19 vaccine increases by 40 times the number of antibodies found in immunocompromised patients.

Recent research from around the world has shown a drop in the number of antibodies starting a few months after the second dose, alongside an extreme and encouraging rise following the administration of a booster dose in the general population.

The Assuta research shows that this data holds true for those who are immunocompromised as well.

No comments :

Post a Comment

please use either your real name or a pseudonym.